← SynDRA
NIFURSOL
SynDRA canonical compound SYN0018732 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | bacterial DNA inhibitor |
|---|
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP2C19
- CYP2C9
- ACHE
- FLT1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- KAT2A
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HSPA5
- HRH2
- HRH1
- HMGCR
- HDAC6
- MMP1
- MMP9
- NPY1R
- PTPRC
- VDR
- TDP1
- TBXAS1
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SIGMAR1
- PTGS2
- NPY2R
- PTGS1
- PTAFR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- CP2C9
- CP2D6
- CP3A7
- GLI3
- NF2L2
Cross-references
Synonyms
- NSC-759632
- Histomon
- Sulfuride
- Nifursolum
- TG99GOU55Z
- NSC 759632
- DTXCID8026226
- CHEBI:172596
- 3,5-dinitrosalicylic acid-(5-nitrofurfurylidene)hydrazide
- RefChem:165806
- Salfuride
- Nifursol (~90%)
- Nifursolo [DCIT]
- Nifursolo
- C12H7N5O9
- Nifursol (USAN)
- MFCD00377430
- NCGC00160555-01
- NIFURSOL [USAN]
- Nifursolum [INN-Latin]
- CAS-16915-70-1
- EINECS 240-963-6
- UNII-TG99GOU55Z
- 3,5-Dinitro-salicylic Acid (5-Nitrofurfurylidene)hydrazide
- Nifursol [USAN:INN:BAN]
- Salicylic acid, 3,5-dinitro-(5-nitrofurfurylidene)hydrazide
- NIFURSOL [INN]
- NIFURSOL [MART.]
- orb1301061
- orb3025273
- SCHEMBL1134228
- SCHEMBL30098414
- XXUXXCZCUGIGPP-WLRTZDKTSA-N
- HMS3264O21
- Pharmakon1600-01502316
- HY-B1703
- MSK11400
- Tox21_111895
- NSC759632
Look up NIFURSOL in the interactive SynDRA portal →